ABBV Nilai Total Aset Perusahaan AbbVie Inc

AbbVie Inc. (ABBV) management effectively diversifies assets through mergers, maintaining a stable cash flow. The holding company is currently introducing new immunological drugs to offset the loss of previous patents. However, threats remain regarding price regulation, debt, and the outcomes of new molecule tests. The current price action of total assets, which amount to 136260.87, clearly demonstrates the scale of this biopharmaceutical behemoth.

ABBV (AbbVie Inc.) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 31.10.2026

Rincian analitis lan laporan data perusahaan Abbvie (ABBV)

- rega saham lan konsensus proyeksi valuasi:

Bagan rega abbvie.com|ABBV - Bagan rega target

- data kapitalisasi pasar:

Biji pasar AbbVie Corp.|ABBV - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi Saham AbbVie|ABBV - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku abbvie.com|ABBV - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi AbbVie Inc.|ABBV - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas AbbVie Corp.|ABBV - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku AbbVie Corp.|ABBV - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan AbbVie|Rasio jangkoan perantara abbvie.com

- indikator pendapatan resik lan kelipatan nilai:

ABBV - Bathi resik perusahaan

Pambiji fundamental:AbbVie Inc.

For AbbVie Inc. (ABBV), this indicator reflects the pharmaceutical behemoth's total resource base, combining equity and debt obligations. The metric is calculated inversely via return on assets (ROA), allowing for an assessment of the actual volume of assets controlled by management. Total asset dynamics demonstrate the efficiency of capital accumulation to support the innovative portfolio. Stable base growth confirms the holding's resilience even during periods of patent expiration for key drugs.

Pesaing wigati